Detalles de la búsqueda
1.
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes.
Hepatology
; 79(5): 1098-1106, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37862551
2.
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH.
Gut
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418210
3.
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
J Hepatol
; 78(3): 471-478, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410554
4.
Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
Radiology
; 304(1): 75-82, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348378
5.
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Gut
; 70(10): 1946-1953, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33214165
6.
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
Hepatology
; 71(3): 849-860, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31556124
7.
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes.
Clin Gastroenterol Hepatol
; 18(3): 744-746.e1, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31100460
8.
Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
Clin Gastroenterol Hepatol
; 18(8): 1842-1850.e6, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31843596
9.
Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography.
Hepatology
; 70(1): 127-141, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859582
10.
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
Clin Gastroenterol Hepatol
; 17(4): 630-637.e8, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908362
11.
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology
; 155(2): 307-310.e2, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29660324
12.
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.
Hepatology
; 68(3): 918-932, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29572891
13.
Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
Hepatology
; 67(4): 1348-1359, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29108123
14.
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease.
Clin Gastroenterol Hepatol
; 16(12): 1974-1982.e7, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29104128
15.
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
Gastroenterology
; 152(3): 598-607.e2, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27911262
16.
Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
Eur Radiol
; 28(4): 1345-1355, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29058029
17.
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.
Hepatology
; 64(5): 1547-1558, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27315352
18.
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
J Hepatol
; 65(2): 369-76, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27151177
19.
Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
Clin Gastroenterol Hepatol
; 14(9): 1337-1344.e3, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26820400
20.
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.
Gastroenterology
; 149(7): 1784-93, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26299412